Medigen Biotechnology Corp.

Research Medigen Biotechnology Corp. (3176.TWO) on Bullrun: market cap TWD 4.95B. Explore financials, valuation history, model signals, and stock context.

Key Metrics

Ticker3176.TWO
ExchangeTWO
CountryTaiwan
SectorHealthcare
IndustryBiotechnology
CurrencyTWD
Market capTWD 4.95B
Financial periodQ2 2026
RevenueTWD 284.74M
Net income-TWD 25.98M
Free cash flow-TWD 360.30M
Gross margin59.9%

Valuation Snapshot

latest market cap is TWD 4.95B.

Valuation history

Year	Snapshot date	Market cap	P/E	Dividend yield	Annual dividend/share
2026	2026-10-18	TWD 4.95B	n/a	n/a	0

Dividend history

Latest trailing dividend snapshot: annual dividend/share 0 TWD.

About Medigen Biotechnology Corp.

Medigen Biotechnology Corp., a biopharmaceutical company, engages in the research and development of new drugs and vaccines, cell therapy, advanced nucleic acid testing, generic drugs, medical beauty, and vaccine-related products in Taiwan. It offers cell therapies, such as MAGICELL-NK, which are natural killer cells; and MAGICELL-GDT, which are T cells. It also develops OBP-301 that has completed Phase I clinical trials in combination with esophageal cancer in Japan;

Related stock research

Taiwan stocks Taiwan Healthcare stocks A-Z stock index

Other Healthcare stocks

Synbio Tech Inc. (1295.TWO) Sinphar Pharmaceutical Co.,Ltd. (1734.TW) Chunghwa Chemical Synthesis & Biotech Co., Ltd. (1762.TW) SYN-TECH Chem. & Pharm. Co., Ltd. (1777.TWO) Level Biotechnology Inc. (3118.TWO) GenMont Biotech Incorporation (3164.TW) Sagittarius Life Science Corp (3205.TWO) NeoCore Technology Co., Ltd. (4131.TWO) Abnova (Taiwan) Corporation (4133.TW) Adimmune Corporation (4142.TW) TaiMed Biologics Inc. (4147.TWO) TaiGen Biopharmaceuticals Holdings Limited (4157.TWO)

Frequently asked questions

What is Medigen Biotechnology Corp.'s market cap?

Medigen Biotechnology Corp.'s market capitalization is TWD 4.95B.